Willow Biosciences, Inc. is a biotechnology company. It develops synthetic biology solutions for opioid biosynthesis. The firm offers biosynthetic production systems for plant-derived active pharmaceutical ingredients (API) and intermediates. The company operates through the following segments: Research and Development, Analytical Testing, and Corporate. Willow Biosciences was founded on April 15, 1981 and is headquartered in Calgary, Canada.